Tower Research Capital (TRC)’s Inhibikase Therapeutics IKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $195 | Buy |
+100
| New | +$195 | ﹤0.01% | 5108 |
|
|
2024
Q4 | – | Sell |
-4,057
| Closed | -$5.27K | – | 5832 |
|
|
2024
Q3 | $5.27K | Sell |
4,057
-1,679
| -29% | -$2.18K | ﹤0.01% | 4299 |
|
|
2024
Q2 | $6.94K | Buy |
5,736
+2,965
| +107% | +$3.59K | ﹤0.01% | 4519 |
|
|
2024
Q1 | $5.99K | Sell |
2,771
-3,148
| -53% | -$6.8K | ﹤0.01% | 4456 |
|
|
2023
Q4 | $7.52K | Buy |
5,919
+3,719
| +169% | +$4.72K | ﹤0.01% | 4610 |
|
|
2023
Q3 | $3.06K | Buy |
2,200
+216
| +11% | +$300 | ﹤0.01% | 5061 |
|
|
2023
Q2 | $7.16K | Sell |
1,984
-238
| -11% | -$859 | ﹤0.01% | 4589 |
|
|
2023
Q1 | $9K | Buy |
2,222
+420
| +23% | +$1.7K | ﹤0.01% | 4500 |
|
|
2022
Q4 | $5K | Buy |
1,802
+774
| +75% | +$2.15K | ﹤0.01% | 4871 |
|
|
2022
Q3 | $6K | Sell |
1,028
-1,642
| -61% | -$9.58K | ﹤0.01% | 5020 |
|
|
2022
Q2 | $12K | Buy |
2,670
+2,404
| +904% | +$10.8K | ﹤0.01% | 4283 |
|
|
2022
Q1 | $2K | Sell |
266
-801
| -75% | -$6.02K | ﹤0.01% | 5559 |
|
|
2021
Q4 | $10K | Buy |
1,067
+166
| +18% | +$1.56K | ﹤0.01% | 4569 |
|
|
2021
Q3 | $10K | Buy |
+901
| New | +$10K | ﹤0.01% | 4318 |
|
|
2021
Q2 | – | Sell |
-91
| Closed | -$3K | – | 5642 |
|
|
2021
Q1 | $3K | Buy |
+91
| New | +$3K | ﹤0.01% | 4901 |
|